Variant report

Variant	esv3355439
Chromosome Location	chr17:16944752-16947600
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr17:16947565-16947765	K562	blood:	n/a	n/a
2	ATF2	chr17:16945114-16945377	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr17:16945197-16945464	H1-hESC	embryonic stem cell:	n/a	n/a
4	BCL3	chr17:16944229-16945718	A549	lung:	n/a	n/a
5	BCL3	chr17:16946243-16947518	A549	lung:	n/a	chr17:16947227-16947236 chr17:16946450-16946459
6	BHLHE40	chr17:16945306-16945678	K562	blood:	n/a	chr17:16945484-16945500 chr17:16945492-16945508
7	BHLHE40	chr17:16944614-16944869	K562	blood:	n/a	n/a
8	BHLHE40	chr17:16945372-16945724	GM12878	blood:	n/a	chr17:16945484-16945500 chr17:16945492-16945508
9	BHLHE40	chr17:16946787-16946940	K562	blood:	n/a	n/a
10	BRCA1	chr17:16946847-16947072	Hela-S3	cervix:	n/a	n/a
11	BRCA1	chr17:16945568-16945643	HepG2	liver:	n/a	n/a
12	BRCA1	chr17:16945406-16945615	Hela-S3	cervix:	n/a	n/a
13	CBX3	chr17:16945009-16945376	K562	blood:	n/a	n/a
14	CCNT2	chr17:16945280-16945715	K562	blood:	n/a	n/a
15	CEBPB	chr17:16945377-16945549	K562	blood:	n/a	n/a
16	CEBPB	chr17:16945550-16945551	H1-hESC	embryonic stem cell:	n/a	n/a
17	CEBPB	chr17:16945498-16945589	Hela-S3	cervix:	n/a	n/a
18	CEBPD	chr17:16945407-16945685	HepG2	liver:	n/a	n/a
19	CHD2	chr17:16945200-16945824	GM12878	blood:	n/a	n/a
20	CHD2	chr17:16945367-16945802	H1-hESC	embryonic stem cell:	n/a	n/a
21	CHD2	chr17:16946904-16947302	Hela-S3	cervix:	n/a	n/a
22	CHD2	chr17:16945385-16945804	K562	blood:	n/a	n/a
23	CHD2	chr17:16945185-16945709	HepG2	liver:	n/a	n/a
24	CHD2	chr17:16945086-16945870	Hela-S3	cervix:	n/a	n/a
25	CREB1	chr17:16945094-16945877	HepG2	liver:	n/a	n/a
26	CREB1	chr17:16945238-16945864	A549	lung:	n/a	n/a
27	CREB1	chr17:16945365-16945771	GM12878	blood:	n/a	n/a
28	CREB1	chr17:16945326-16945734	H1-hESC	embryonic stem cell:	n/a	n/a
29	CREB1	chr17:16946610-16946943	A549	lung:	n/a	n/a
30	CTBP2	chr17:16944611-16945680	H1-hESC	embryonic stem cell:	n/a	n/a
31	CTCF	chr17:16946320-16946470	GM06990	blood:	n/a	n/a
32	CTCF	chr17:16945495-16945639	Spleen_OC	spleen:	n/a	n/a
33	CTCF	chr17:16947120-16947270	AG04449	skin:	n/a	n/a
34	CUX1	chr17:16945060-16945224	GM12878	blood:	n/a	n/a
35	CUX1	chr17:16947482-16947696	K562	blood:	n/a	n/a
36	E2F4	chr17:16945292-16945536	GM12878	blood:	n/a	chr17:16945402-16945414 chr17:16945401-16945416
37	E2F4	chr17:16945193-16945765	MCF10A-Er-Src	breast:	n/a	chr17:16945647-16945661 chr17:16945402-16945414 chr17:16945549-16945559 chr17:16945401-16945416
38	E2F6	chr17:16945932-16946065	K562	blood:	n/a	chr17:16945946-16945957
39	E2F6	chr17:16945330-16945624	K562	blood:	n/a	chr17:16945402-16945414 chr17:16945549-16945559 chr17:16945401-16945416
40	E2F6	chr17:16945849-16946086	K562	blood:	n/a	chr17:16945946-16945957
41	E2F6	chr17:16945256-16946203	K562	blood:	n/a	chr17:16945647-16945661 chr17:16945946-16945957 chr17:16945402-16945414 chr17:16945549-16945559 chr17:16945401-16945416
42	EBF1	chr17:16945540-16945680	GM12878	blood:	n/a	n/a
43	EGR1	chr17:16945252-16945700	H1-hESC	embryonic stem cell:	n/a	chr17:16945400-16945410 chr17:16945471-16945485 chr17:16945607-16945620 chr17:16945397-16945407
44	EGR1	chr17:16945236-16945648	ECC-1	luminal epithelium:	n/a	chr17:16945400-16945410 chr17:16945471-16945485 chr17:16945607-16945620 chr17:16945397-16945407
45	EGR1	chr17:16945136-16945751	ECC-1	luminal epithelium:	n/a	chr17:16945400-16945410 chr17:16945471-16945485 chr17:16945607-16945620 chr17:16945397-16945407
46	EGR1	chr17:16945168-16945722	MCF-7	breast:	n/a	chr17:16945400-16945410 chr17:16945471-16945485 chr17:16945607-16945620 chr17:16945397-16945407
47	EGR1	chr17:16945152-16945706	K562	blood:	n/a	chr17:16945400-16945410 chr17:16945471-16945485 chr17:16945607-16945620 chr17:16945397-16945407
48	EGR1	chr17:16945305-16945610	GM12878	blood:	n/a	chr17:16945400-16945410 chr17:16945471-16945485 chr17:16945397-16945407
49	EGR1	chr17:16945313-16945717	GM12878	blood:	n/a	chr17:16945400-16945410 chr17:16945471-16945485 chr17:16945607-16945620 chr17:16945397-16945407
50	EGR1	chr17:16945205-16945664	K562	blood:	n/a	chr17:16945400-16945410 chr17:16945471-16945485 chr17:16945607-16945620 chr17:16945397-16945407

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:16945596-16945646	SK-N-SH	brain:	n/a
2	chr17:16945596-16945646	SK-N-SH	brain:	n/a
3	chr17:16946995-16947045	PrEC	prostate:	n/a
4	chr17:16947406-16947456	AoSMC	blood vessel:	n/a
5	chr17:16945385-16945435	HPAEpiC	pulmonary alveolar:	n/a
6	chr17:16946995-16947045	HRCEpiC	kidney:	n/a
7	chr17:16945603-16945653	T-47D	breast:	n/a
8	chr17:16946247-16946297	A549	lung:	n/a
9	chr17:16945298-16945348	HL-60	blood:	n/a
10	chr17:16945385-16945435	GM19239	blood:	n/a
11	chr17:16945603-16945653	H1-hESC	embryonic stem cell:	embryo
12	chr17:16945603-16945653	HL-60	blood:	n/a
13	chr17:16947406-16947456	Hepatocyte	liver:	n/a
14	chr17:16945298-16945348	GM12892	blood:	n/a
15	chr17:16945385-16945435	U87	brain:	n/a
16	chr17:16946247-16946297	SAEC	small airway:	n/a
17	chr17:16945301-16945351	IMR90	lung:	fetal
18	chr17:16945603-16945653	PFSK-1	brain:	n/a
19	chr17:16946995-16947045	AG10803	skin:	n/a
20	chr17:16945298-16945348	PANC-1	pancreas:	n/a
21	chr17:16947406-16947456	HL-60	blood:	n/a
22	chr17:16945385-16945435	AG09319	gingival:	n/a
23	chr17:16947406-16947456	H1-hESC	embryonic stem cell:	embryo
24	chr17:16946995-16947045	HEK293	kidney:	embryo
25	chr17:16945298-16945348	GM06990	blood:	n/a
26	chr17:16946247-16946297	Caco-2	colon:	n/a
27	chr17:16945301-16945351	HRCEpiC	kidney:	n/a
28	chr17:16947406-16947456	AG04450	lung:	fetal
29	chr17:16945298-16945348	HAEpiC	amniotic membrane:	n/a
30	chr17:16945301-16945351	AG09319	gingival:	n/a
31	chr17:16945301-16945351	HEK293	kidney:	embryo
32	chr17:16945596-16945646	HL-60	blood:	n/a
33	chr17:16946995-16947045	AG04450	lung:	fetal
34	chr17:16946247-16946297	AoSMC	blood vessel:	n/a
35	chr17:16945603-16945653	MCF10A-Er-Src	breast:	n/a
36	chr17:16945603-16945653	SKMC	muscle:	n/a
37	chr17:16945596-16945646	Hela-S3	cervix:	n/a
38	chr17:16945385-16945435	NH-A	brain:	n/a
39	chr17:16945301-16945351	MCF-7	breast:	n/a
40	chr17:16946247-16946297	RPTEC	kidney:	n/a
41	chr17:16945301-16945351	NHDF-neo	bronchial:	n/a
42	chr17:16945603-16945653	AG04449	skin:	fetal
43	chr17:16945301-16945351	GM12892	blood:	n/a
44	chr17:16946247-16946297	IMR90	lung:	fetal
45	chr17:16945603-16945653	HCM	heart:	n/a
46	chr17:16946247-16946297	NT2-D1	testis:	n/a
47	chr17:16945596-16945646	HMEC	breast:	n/a
48	chr17:16947406-16947456	SK-N-SH	brain:	n/a
49	chr17:16947406-16947456	SAEC	small airway:	n/a
50	chr17:16945301-16945351	BE2_C	brain:	n/a

No.	Distal block	Cell Line	Cell type
1	chr17:16945686..16947847-chr3:44621097..44624084,2	MCF-7	breast:
2	chr17:16944952..16946961-chr17:17072835..17074607,2	K562	blood:
3	chr17:16947403..16948944-chr17:16950340..16952252,2	MCF-7	breast:
4	chr17:16943176..16945630-chr17:17102978..17105800,2	K562	blood:
5	chr17:16944416..16947050-chr17:16979219..16983384,3	MCF-7	breast:
6	chr17:16944536..16947207-chr17:17109103..17111480,2	MCF-7	breast:
7	chr17:16917707..16920531-chr17:16944662..16947361,2	MCF-7	breast:

Variant related genes	Relation type
MPRIP	TF binding region
MPRIP	CpG island
ENSG00000179598	chromatin interactions
ENSG00000260328	chromatin interactions
ENSG00000225442	chromatin interactions
ENSG00000214820	chromatin interactions
ENSG00000206859	chromatin interactions
ENSG00000133030	chromatin interactions

Extended variants
information (count: 90 )
Associated
traits (count: 160 )

Variant overlapped rSNPs/rCNVs (count:90 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs11869423	chr17:16944759-16944760	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs556109692	chr17:16944818-16944819	Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
3	rs576143307	chr17:16944883-16944884	Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
4	rs545058936	chr17:16944969-16944970	Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
5	rs111318776	chr17:16944981-16944982	Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
6	rs141362415	chr17:16944982-16944983	Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
7	rs541472777	chr17:16945032-16945033	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
8	rs561657473	chr17:16945057-16945058	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
9	rs373670232	chr17:16945130-16945131	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
10	rs191693259	chr17:16945155-16945156	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
11	rs563237708	chr17:16945198-16945199	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
12	rs532250377	chr17:16945206-16945207	Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
13	rs552349983	chr17:16945261-16945262	Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
14	rs561693523	chr17:16945323-16945324	Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
15	rs72837920	chr17:16945338-16945339	Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
16	rs534853556	chr17:16945392-16945393	Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
17	rs541348256	chr17:16945415-16945416	Active TSS Weak transcription Flanking Active TSS	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
18	rs548059780	chr17:16945511-16945512	Active TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
19	rs568365825	chr17:16945537-16945538	Active TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
20	rs564361935	chr17:16945542-16945543	Active TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
21	rs370974609	chr17:16945559-16945560	Active TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
22	rs78365041	chr17:16945586-16945587	Active TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
23	rs146980993	chr17:16945594-16945595	Active TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
24	rs538642193	chr17:16945601-16945602	Active TSS Weak transcription Enhancers	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
25	rs558665329	chr17:16945608-16945609	Active TSS Weak transcription Enhancers	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
26	rs113484313	chr17:16945671-16945672	Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
27	rs552414952	chr17:16945735-16945736	Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
28	rs185563953	chr17:16945738-16945739	Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
29	rs202229094	chr17:16945767-16945768	Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
30	rs7503606	chr17:16945791-16945792	Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
31	rs3898611	chr17:16945938-16945939	Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
32	rs575090383	chr17:16946021-16946022	Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
33	rs544085101	chr17:16946035-16946036	Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
34	rs563970194	chr17:16946050-16946051	Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
35	rs575524053	chr17:16946073-16946074	Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
36	rs532186196	chr17:16946118-16946119	Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
37	rs376448844	chr17:16946125-16946126	Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
38	rs370695421	chr17:16946126-16946127	Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
39	rs552187205	chr17:16946142-16946143	Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
40	rs138437542	chr17:16946210-16946211	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
41	rs145264583	chr17:16946218-16946219	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
42	rs528147462	chr17:16946312-16946313	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
43	rs182104879	chr17:16946315-16946316	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
44	rs568121895	chr17:16946342-16946343	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
45	rs61242604	chr17:16946343-16946344	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS	Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
46	rs550507737	chr17:16946348-16946349	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
47	rs570402665	chr17:16946355-16946356	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
48	rs538680075	chr17:16946388-16946389	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
49	rs558656157	chr17:16946394-16946395	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
50	rs563169847	chr17:16946395-16946396	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:160)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Burkitt''s lymphoma	19759907	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Acute myeloid leukemia	17237825	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Colorectal cancer	16774939	CNVD
Pancreatic cancer	21811587	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Breast cancer	17603634	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
ovarian endometriomas	16273235	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Gastric cancer	18160780	CNVD
Smith-Magenis syndrome	18923513	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22492990	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	18414209	CNVD
Developmental delay	21549014	CNVD
Epilepsy	20970697	CNVD
Mental retardation	18414209	CNVD
Mental retardation	21549014	CNVD
Smith-Magenis syndrome	21981782	CNVD
Smith-Magenis syndrome	20188345	CNVD
Smith-Magenis syndrome	16775514	CNVD
Smith-Magenis syndrome	22585170	CNVD
Smith-Magenis syndrome	22241247	CNVD
Autism	20970697	CNVD
Mental retardation	19951919	CNVD
Potocki-Lupski syndrome	21271655	CNVD
Potocki-lupski syndrome	17357070	CNVD
Potocki-lupski syndrome	20110824	CNVD
Potocki-lupski syndrome	18923514	CNVD
Potocki-lupski syndrome	22241247	CNVD
Potocki-lupski syndrome	20188345	CNVD
Schizophrenia	21399695	CNVD
Mental retardation	16773131	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Charcot-marie-tooth disease	22470819	CNVD
Neurofibromatosis	22470819	CNVD
Neuropathy	22470819	CNVD
Smith-Magenis syndrome	18301319	CNVD
Smith-Magenis syndrome	17357070	CNVD
Smith-Magenis syndrome	18469339	CNVD
Smith-Magenis syndrome	22241097	CNVD
Smith-Magenis syndrome	22470819	CNVD
Tourette syndrome	18923514	CNVD
Type 1 diabetes	22470819	CNVD
Potocki-lupski syndrome	18469339	CNVD
Follicular lymphoma	20505157	CNVD
T-cell lymphomas	19863542	CNVD
Neuropathy	17597781	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	17015230	CNVD
Smith-Magenis syndrome	17597781	CNVD
Potocki-lupski syndrome	18059269	CNVD
Potocki-lupski syndrome	17597781	CNVD
Mental retardation	17847001	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	20409316	CNVD
Breast cancer	21509527	CNVD
Ductal carcinoma	22052326	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Multiple myeloma	17550852	CNVD
Breast cancer	22522925	CNVD
Lung adenocarcinoma	21935476	CNVD

Chromatin state (count:559 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:16935800-16945200	Weak transcription	Aorta	Aorta
2	chr17:16936000-16944800	Weak transcription	Brain Angular Gyrus	brain
3	chr17:16936000-16944800	Weak transcription	Esophagus	oesophagus
4	chr17:16936200-16944800	Weak transcription	HUVEC	blood vessel
5	chr17:16940400-16944800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
6	chr17:16940400-16944800	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
7	chr17:16940400-16944800	Weak transcription	Right Atrium	heart
8	chr17:16940600-16944800	Weak transcription	Primary B cells from cord blood	blood
9	chr17:16940600-16944800	Weak transcription	Primary B cells from peripheral blood	blood
10	chr17:16940600-16945000	Weak transcription	Primary hematopoietic stem cells	blood
11	chr17:16941800-16945000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
12	chr17:16942000-16945000	Enhancers	Fetal Intestine Large	intestine
13	chr17:16942600-16945000	Enhancers	Fetal Intestine Small	intestine
14	chr17:16943200-16945000	Enhancers	Fetal Muscle Trunk	muscle
15	chr17:16943200-16945000	Enhancers	Fetal Muscle Leg	muscle
16	chr17:16943400-16945000	Enhancers	Fetal Brain Male	brain
17	chr17:16943600-16945000	Weak transcription	Ovary	ovary
18	chr17:16944200-16944800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
19	chr17:16944200-16944800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
20	chr17:16944200-16944800	Enhancers	Stomach Smooth Muscle	stomach
21	chr17:16944200-16944800	Flanking Active TSS	HepG2	liver
22	chr17:16944200-16944800	Enhancers	NHLF	lung
23	chr17:16944200-16945000	Enhancers	HMEC	breast
24	chr17:16944200-16945000	Enhancers	NHDF-Ad	bronchial
25	chr17:16944200-16945200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
26	chr17:16944200-16945200	Enhancers	Placenta	Placenta
27	chr17:16944200-16945400	Flanking Active TSS	HSMM	muscle
28	chr17:16944400-16944800	Enhancers	ES-I3 Cell Line	embryonic stem cell
29	chr17:16944400-16944800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
30	chr17:16944400-16944800	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
31	chr17:16944400-16944800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
32	chr17:16944400-16944800	Enhancers	Primary hematopoietic stem cells short term culture	blood
33	chr17:16944400-16944800	Active TSS	Brain Inferior Temporal Lobe	brain
34	chr17:16944400-16944800	Enhancers	Colon Smooth Muscle	Colon
35	chr17:16944400-16944800	Active TSS	Psoas Muscle	Psoas
36	chr17:16944400-16944800	Enhancers	NHEK	skin
37	chr17:16944400-16944800	Enhancers	Osteobl	bone
38	chr17:16944400-16945000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
39	chr17:16944400-16945000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
40	chr17:16944400-16945000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
41	chr17:16944400-16945000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
42	chr17:16944400-16945000	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
43	chr17:16944400-16945000	Enhancers	Cortex derived primary cultured neurospheres	brain
44	chr17:16944400-16945000	Enhancers	Brain Substantia Nigra	brain
45	chr17:16944400-16945000	Enhancers	Right Ventricle	heart
46	chr17:16944400-16945000	Enhancers	Stomach Mucosa	stomach
47	chr17:16944400-16945200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
48	chr17:16944400-16945200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
49	chr17:16944400-16945200	Enhancers	Breast Myoepithelial Primary Cells	Breast
50	chr17:16944400-16945200	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links